Insulin acts as a repressive factor to inhibit the ability of PAR2 to induce islet cell transdifferentiation.
Ontology highlight
ABSTRACT: Recently, we showed that pancreatitis in the context of profound β-cell deficiency was sufficient to induce islet cell transdifferentiation. In some circumstances, this effect was sufficient to result in recovery from severe diabetes. More recently, we showed that the molecular mechanism by which pancreatitis induced β-cell neogenesis by transdifferentiation was activation of an atypical GPCR called Protease-Activated Receptor 2 (PAR2). However, the ability of PAR2 to induce transdifferentiation occurred only in the setting of profound β-cell deficiency, implying the existence of a repressive factor from those cells. Here we show that the repressor from β-cells is insulin. Treatment of primary islets with a PAR2 agonist (2fLI) in combination with inhibitors of insulin secretion and signali
SUBMITTER: Lee SH
PROVIDER: S-EPMC6300087 | biostudies-literature | 2018 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA